Majid Tabbakhian

Majid Tabbakhian

Auto-generated profile, based on publicly available information

Majid Tabbakhian

Novel Drug Delivery Systems Research Center, Department of Pharmaceutics, School of Pharmacy Isfahan University of Medical Sciences, Isfahan, Iran

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2006 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
MTMajid Tabbakhian
Majid Tabbakhian
NTNaser Tavakoli
Naser Tavakoli
MJMahmoud Reza Jaafari
Mahmoud Reza Jaafari
SDSaeid Daneshamouz
Saeid Daneshamouz

1 May 2012 in Carbohydrate Polymers
Verified
Journal Article
Closed access
JVJaleh Varshosaz
Jaleh Varshosaz
Sharareh EskandariSharareh Eskandari
Sharareh Eskandari
MTMajid Tabbakhian
Majid Tabbakhian

3 December 2009 in Journal of Liposome Research
Verified
Journal Article
Closed access
PDF file
JVJaleh Varshosaz
Jaleh Varshosaz
MTMajid Tabbakhian
Majid Tabbakhian
MMMahboobeh Y. Mohammadi
Mahboobeh Y. Mohammadi
Solid lipid nanoparticles (SLNs) of buspirone HCl as a water-soluble drug were prepared by emulsification-evaporation, followed by the sonification method. A preliminary screening of the most effective parameters on the production of nanoparticles by a Taguchi L8 orthogonal array showed that the lipid type, surfactant percentage, speed of homogenizer, and acetone:dichloromethane (DCM) ratio had a significant effect on particle size. In the next step, the lipid was fixed on cetyl alcohol, surfactant on Tween 20, lecithin:lipid weight ratio on 20:70, sonication time on 30 seconds, and the other effective, independent factors aforementioned were studied each at three levels by a three-factor, three-level Box-Behnken design. The percentage of drug entrapment, mean particle-size diameter, and zeta potential were studied as the responses. Contour plots were constructed to further elucidate the relationship between the independent and dependent variables. A pharmacokinetic study was conducted in male Wistar rats after oral administration of 15 mg.kg−1 buspirone in the form of free drug or SLNs. The optimized SLNs had aq particle size of 345.7 nm, loading efficiency of 32.8%, and zeta potential of −6.8 mV. Buspirone released about 90% during 4.5 hours in vitro. It was found that the relative bioavailability of the drug in SLNs was significantly increased, compared to that of the drug solution.

20 January 2010 in Pharmaceutical Development and Technology
Verified
Journal Article
Closed access
PDF file
JVJaleh Varshosaz
Jaleh Varshosaz
Sharareh EskandariSharareh Eskandari
Sharareh Eskandari
MTMajid Tabakhian
Majid Tabakhian
The objective of this study was production of nanostructured lipid carriers (NLC) of valproic acid for brain delivery thought the nasal pathway. NLC were prepared by solvent diffusion method using a Taguchi design. The lipid, oil and valproic acid were dissolved in organic phase then dispersed in aqueous phase containing the surfactant. The most effective factors on size were surfactant concentration, organic/aqueous phase ratio and acetone/ethanol volume ratio. Zeta potential was more affected by the lipid type, while the surfactant concentration and sonication time were more effective variables on drug release rate. The entrapment efficiency was more affected by lipid/drug weight ratio. Optimum formulation obtained with 400 mg lipid, 400 mg valproic acid, 2% surfactant, 1:5 organic/aqueous phase ratio, 1:1 acetone/ethanol volume ratio and 2 min sonication.

1 January 2012 in Journal of Nanomaterials
Verified
Journal Article
Open access
PDF file
JEJaber Emami
Jaber Emami
MRMahboubeh Rezazadeh
Mahboubeh Rezazadeh
JVJaleh Varshosaz
Jaleh Varshosaz
MTMajid Tabbakhian
Majid Tabbakhian
AAAbolfazl Aslani
Abolfazl Aslani
In the present study, cholesterol nanostructured lipid carriers with various oleic acid content loaded with paclitaxel (PTX) were prepared by solvent emulsification‐diffusion method using a Taguchi design. Size, zeta potential, entrapment efficiency, drug loading, and release percent of NLCs were measured. The results indicated that the most effective factors on the size were oleic acid content and surfactant percent. Zeta potential was more affected by the drug content. Drug to‐ lipid weight ratio was the most effective factor on entrapment efficiency and drug release from NLC. In the present work, the effect of lyophilization on the particle size and release properties of NLCs was also evaluated. The results revealed no differences between the characteristics of NLCs before and after freeze drying by using 25% w/w sorbitol as cryoprotectant. Cytotoxicity studies indicate that PTX associated with the NLC is also effective in HT‐29 cell lines and enters the cancer cells selectively through the LDL receptor endocytic pathway. The IC50 values of free PTX solubilized in Cremophor EL and NLC‐born PTX after 72 h exposure were 8.32 ± 1.35 ng/mL and 5.24 ± 0.96 ng/mL, respectively.

1 April 2017 in Journal of Research in Pharmacy Practice
Verified
Journal Article
Open access
PDF file
MSMansour Siavash
Mansour Siavash
MTMajid Tabbakhian
Majid Tabbakhian
ASAli Mohammad Sabzghabaee
Ali Mohammad Sabzghabaee
NRNiloufar Razavi
Niloufar Razavi
Objective: This study was designed to compare the severity of gastrointestinal (GI) side effects in Type 2 diabetes mellitus (DM) patients receiving tablet or capsule forms of metformin. Methods: In this prospective interventional study, patients were evaluated from June to November 2016 at DM clinics affiliated to Isfahan University of Medical Sciences, Isfahan, Iran. Adult patients with Type 2 DM who were eligible for inclusion criteria switched from metformin tablet to metformin capsule. Hemoglobin A1c (HbA1c), GI side effects, and patient satisfaction based on visual analog scale (VAS) were assessed during a 6-week follow-up of receiving metformin capsule. Findings: One hundred and three patients were evaluated, and 75 patients participated in this study. At the baseline, 40 patients (53.3%) had GI side effects due to metformin tablet which was reduced to 16 patients (21.3%) after switching to metformin capsule (P = 0.001). There was also an improvement in HbA1c (from 7 to 6.8,P < 0.0001). The results of patients’ satisfaction based on VAS and numeric rating scale indicated that in 59 patients (78.67%), GI side effects were reduced after switching to metformin capsule (mean score: 7.2 with the range of 6–9) while 16 patients stated no treatment preference. Conclusion: Switching to metformin capsule may result in less GI side effects, with no further side effect complications.